[1] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the heart rhythm society[J]. Circulation, 2014, 130(23):e199-267.
[2] Hayashi K, Tada H, Yamagishi M. The genetics of atrial fibrillation[J]. Curr Opin Cardiol, 2017, 32(1):10-16.
[3] Zhou M, Liao Y, Tu X. The role of transcription factors in atrial fibrillation[J]. J Thorac Dis, 2015, 7(2):152-158.
[4] Li N, Wang ZS, Wang XH, et al. A SHOX2 loss-of-function mutation underlying familial atrial fibrillation[J]. Int J Med Sci, 2018, 15(13):1564-1572.
[5] 李文昭, 徐迎佳, 李若谷, 等. 特发性扩张型心肌病相关GATA6基因新突变的识别[J]. 国际心血管病杂志, 2018, 45(5):288-291.
[6] Puskaric S, Schmitteckert S, Mori AD, et al. Shox2 mediates Tbx5 activity by regulating Bmp4 in the pacemaker region of the developing heart[J]. Hum Mol Genet, 2010, 19(23):4625-4633.
[7] Ma JF, Yang F, Mahida SN, et al. TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians[J]. Cardiovasc Res, 2016, 109(3):442-450.
[8] Wang ZC, Ji WH, Ruan CW, et al. Prevalence and spectrum of TBX5 mutation in patients with lone atrial fibrillation[J]. Int J Med Sci, 2016, 13(1):60-67.
[9] Macri V, Mahida SN, Zhang ML, et al. A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation[J]. Heart Rhythm, 2014, 11(6):1055-1062.
[10] Yu H, Xu JH, Song HM, et al. Mutational spectrum of the NKX2-5 gene in patients with lone atrial fibrillation[J]. Int J Med Sci, 2014, 11(6):554-563.
[11] Gollob MH, Jones DL, Krahn AD, et al. Somatic mutations in the connexin 40 gene(GJA5)in atrial fibrillation[J]. N Engl J Med, 2006, 354(25):2677-2688.
[12] Thibodeau IL, Xu J, Li Q, et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue[J]. Circulation, 2010, 122(3):236-244.
[13] Hodgson-Zingman DM, Karst ML, Zingman LV, et al. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation[J]. N Engl J Med, 2008, 359(2):158-165.
[14] Blaschke RJ, Hahurij ND, Kuijper S, et al. Targeted mutation reveals essential functions of the homeodomain transcription factor Shox2 in sinoatrial and pacemaking development[J]. Circulation, 2007, 115(14):1830-1838.
[15] Espinoza-Lewis RA, Yu L, He F, et al. Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5[J]. Dev Biol, 2009, 327(2):376-385.
[16] Hoffmann S, Berger IM, Glaser A, et al. Islet1 is a direct transcriptional target of the homeodomain transcription factor Shox2 and rescues the Shox2-mediated bradycardia[J]. Basic Res Cardiol, 2013, 108(2):339.
[17] Chen YC, Lu YY, Cheng CC, et al. Sinoatrial node electrical activity modulates pulmonary vein arrhythmogenesis[J]. Int J Cardiol, 2014, 173(3):447-452.
[18] Hoffmann S, Clauss S, Berger IM, et al. Coding and non-coding variants in the SHOX2 gene in patients with early-onset atrial fibrillation[J]. Basic Res Cardiol, 2016, 111(3):36.